Nick Leschly

2017 - bluebird bio

In 2017, Nick Leschly earned a total compensation of $8.8M as Chief Executive Officer at bluebird bio, a 80% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$431,200
Option Awards$5,683,090
Salary$560,000
Stock Awards$2,079,000
Other$9,000
Total$8,762,290

Leschly received $5.7M in option awards, accounting for 65% of the total pay in 2017.

Leschly also received $431.2K in non-equity incentive plan, $560K in salary, $2.1M in stock awards and $9K in other compensation.

Rankings

In 2017, Nick Leschly's compensation ranked 808th out of 14,666 executives tracked by ExecPay. In other words, Leschly earned more than 94.5% of executives.

ClassificationRankingPercentile
All
808
out of 14,666
95th
Division
Manufacturing
268
out of 5,770
95th
Major group
Chemicals And Allied Products
65
out of 2,074
97th
Industry group
Drugs
45
out of 1,730
97th
Industry
Biological Products, Except Diagnostic Substances
7
out of 316
98th
Source: SEC filing on April 27, 2018.

Leschly's colleagues

We found four more compensation records of executives who worked with Nick Leschly at bluebird bio in 2017.

2017

Jeffrey Walsh

bluebird bio

Chief Financial and Strategy Officer

2017

David Davidson

bluebird bio

Chief Medical Officer

2017

Philip Gregory

bluebird bio

Chief Scientific Officer

2017

Jason Cole

bluebird bio

Chief Legal Officer

News

In-depth

You may also like